HIGHLIGHTS
- who: Michal Mego from the of Pisa, Italy have published the paper: Vitamin D and circulating tumor cells in primary breast cancer, in the Journal: (JOURNAL)
- what: The aim of this study was to assess plasma vitamin D levels in primary breast cancer (BC) patients in relation to CTCs. This study has several limitations, including small sample size and subsequent underrepresentation of some important subgroups like the HER2 molecular subtype.
- future: Studies are needed to dissect if vitamin D supplementation could decrease CTC and improve breast cancer outcomes.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.